Clinical trials
Completed Multiple Sclerosis trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
184 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 3 |
| 2006 | 4 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 16 |
| 2019 | 15 |
| 2020 | 16 |
| 2021 | 21 |
| 2022 | 21 |
| 2023 | 25 |
| 2024 | 14 |
| 2025 | 18 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 184 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gazi University | 26 |
| Hacettepe University | 11 |
| Dokuz Eylul University | 9 |
| Istanbul University - Cerrahpasa | 8 |
| Novartis Pharmaceuticals | 7 |
| Sanko University | 7 |
| Ankara Yildirim Beyazıt University | 6 |
| Kahramanmaras Sutcu Imam University | 6 |
| Pamukkale University | 5 |
| Ondokuz Mayıs University | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis | 184 |
| Fatigue | 31 |
| Multiple Sclerosis, Relapsing-Remitting | 16 |
| Sleep Initiation and Maintenance Disorders | 9 |
| Pain | 6 |
| Anxiety Disorders | 5 |
| Recurrence | 5 |
| Urinary Incontinence | 5 |
| Kinesiophobia | 4 |
| Lower Urinary Tract Symptoms | 3 |
Trials
Showing 1 to 25 of 184. Each trial links to its page on Pharma Observatory.
84 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.